Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
15 Cards in this Set
- Front
- Back
|
FDA CODE
A |
Drug products that are considered to be therapeuticlly equivallent
|
|
|
FDA CODE
AA |
Products not presenting bioequivalence problems in conventional drug forms
|
|
|
FDA CODE
AB |
Products meeting necessary bioequivalence requirements
|
|
|
FDA CODE
AO |
Injectable oil solutions that are considered therapeutically equicallent to other pharmaceytically equivallent products.
|
|
|
FDA CODE
AP |
INjectable queous solutions
|
|
|
FDA CODE
AT |
Topical products that are considered therapeutically equivallent to other pharmaceutically equivallent products
|
|
|
FDA CODE
B Codes |
Drug products that the FDA does not consider at this time to be therapeutically equivallent to other pharmaceutically equivallent produts
|
|
|
FDA CODE
BC |
Controlled-release tablets, controlled capsules, and controlled -release injectables (Controlled-release pruducts for which suck bioequivalence data re available have been codes AB
|
|
|
FDA CODE
BD |
Active ingredients and dosage forms with documented bioequivalence problems
|
|
|
FDA CODE
BE |
Enteric- coated oral dosage forms
|
|
|
FDA CODE
BP |
Active ingredients and dosage forms with potential bioequivalence problems
|
|
|
FDA CODE
BR |
Suppositories or enemas for systemic use
|
|
|
FDA CODE
BS |
Products having standard deficiencies
|
|
|
FDA CODE
BT |
Topical products
|
|
|
FDA CODE
|
Insufficient data; these products are presumed to be therapeutic not equivalent until adequate info becomes available for full evaluaiton.
|
